Does GOLIMUMAB Cause C-reactive protein increased? 1,640 Reports in FDA Database
Grow Your Own Natural Pharmacy at Home
Medicinal Garden Kit — 10 healing herbs, 4,818 seeds + step-by-step guide.
According to the FDA Adverse Event Reporting System (FAERS), 1,640 reports of C-reactive protein increased have been filed in association with GOLIMUMAB (SIMPONI ARIA). This represents 2.4% of all adverse event reports for GOLIMUMAB.
1,640
Reports of C-reactive protein increased with GOLIMUMAB
2.4%
of all GOLIMUMAB reports
930
Deaths
1,128
Hospitalizations
How Dangerous Is C-reactive protein increased From GOLIMUMAB?
Of the 1,640 reports, 930 (56.7%) resulted in death, 1,128 (68.8%) required hospitalization, and 785 (47.9%) were considered life-threatening.
Is C-reactive protein increased Listed in the Official Label?
This adverse event is not currently listed in the official FDA drug label for GOLIMUMAB. However, 1,640 reports have been filed with the FAERS database.
What Other Side Effects Does GOLIMUMAB Cause?
Drug ineffective (17,959)
Rheumatoid arthritis (12,272)
Pain (11,443)
Fatigue (9,626)
Off label use (8,764)
Alopecia (8,394)
Rash (8,331)
Joint swelling (8,264)
Arthralgia (7,968)
Abdominal discomfort (7,902)
What Other Drugs Cause C-reactive protein increased?
METHOTREXATE (5,999)
ADALIMUMAB (4,579)
RITUXIMAB (4,060)
ETANERCEPT (3,922)
TOCILIZUMAB (3,719)
INFLIXIMAB (3,621)
LEFLUNOMIDE (3,574)
HYDROXYCHLOROQUINE (3,552)
ABATACEPT (3,451)
SULFASALAZINE (3,096)
Which GOLIMUMAB Alternatives Have Lower C-reactive protein increased Risk?
GOLIMUMAB vs GOLODIRSEN
GOLIMUMAB vs GONADORELIN
GOLIMUMAB vs GONADOTROPHIN, CHORIONIC
GOLIMUMAB vs GOSERELIN
GOLIMUMAB vs GRAMICIDIN